\ fda Archives ~ ScienceBeta

ScienceBeta

Menu

Tag: fda

Edaravone Gets FDA Approval For ALS Treatment

The drug edaravone has been approved by U.S. Food and Drug Administration as an injected treatment for amyotrophic lateral sclerosis (ALS). Edaravone, marketed as Radicava by Mitsubishi Tanabe Pharma in the US, is a nootropic and neuroprotective agent that acts to scavenge free radicals, protecting against oxidative stress, which is a probable factor in ALS […]

Valbenazine Cleared By FDA For Tardive Dyskinesia Treatment

Valbenazine has been approved by the U.S. Food and Drug Administration for treatment of tardive dyskinesia. The drug, marketed under the brand name Ingrezza by Neurocrine Biosciences, becomes the first medication approved for treating the condition. Tardive dyskinesia (TD) is a difficult-to-treat and often incurable form of dyskinesia, a disorder resulting in involuntary, repetitive body […]

Ocrevus Scores FDA Approval As Multiple Sclerosis Treatment

The U.S. Food and Drug Administration has given Roche’s multiple sclerosis drug ocrelizumab, brand name Ocrevus approval for the treatment of both relapsing and primary progressive forms of the disease. Ocrelizumab is a humanized anti-CD20 monoclonal antibody which targets CD20 marker on B lymphocytes. It is a slightly modified version of Biogen/Genentech’s existing therapy Rituxan/Rituximab, […]

Avelumab Approved For Metastatic Merkel Cell Carcinoma Treatment

Accelerated approval has been granted by the FDA for the checkpoint inhibitor avelumab (brand name Bavencio) for the treatment of patients with metastatic Merkel cell carcinoma (MCC), including those who have not received prior chemotherapy. Avelumab is the first FDA-approved treatment for metastatic MCC, the first disease that the drug has been approved to treat. […]